Login / Signup

Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.

David ErritzøeTommaso BarbaMeg J SpriggsFernando E RosasDavid J NuttRobin Lester Carhart-Harris
Published in: Journal of psychopharmacology (Oxford, England) (2024)
Discontinuation of SSRI/SNRIs before psilocybin might diminish response to treatment; however, as we did not test SSRI/SNRI continuation in our trial, we cannot infer such causation. Moreover, the exploratory nature of the analyses makes them hypothesis generating, and not confirmatory. A controlled trial of SSRI/SNRI discontinuation versus continuation prior to psilocybin is urgently required.
Keyphrases
  • major depressive disorder
  • study protocol
  • clinical trial
  • phase iii
  • open label
  • randomized controlled trial
  • mesenchymal stem cells
  • combination therapy